美國國會審查醫療補助詐欺與鴉片類藥物危機
US Congress Reviews Medicaid Fraud and Opioid Crisis
Updated at: June 25, 2026 at 02:15 AM
截至2026年6月，美國國會已加強對醫療補助計畫(Medicaid)完整性的關注。
As of June 2026, the U.S.
醫療補助計畫為近7500萬名美國人提供服務，預算超過6000億美元，已成為調查詐欺、浪費和濫用行為的主要目標。
Congress has intensified its focus on the integrity of the Medicaid program.
議員們目前正在審查各州是否具備必要的監督工具，以保護這個關鍵的安全網免受複雜騙局的侵害，這些騙局包括空殼醫療提供者，以及安寧療護和居家照護計畫中的不當帳單。
Serving nearly 75 million Americans with a budget exceeding $600 billion, Medicaid has become a primary target for investigations into fraud, waste, and abuse.
一個主要的擔憂領域是這些金融犯罪與全國鴉片類藥物流行之間的關聯。
Lawmakers are currently examining whether states possess the oversight tools necessary to protect this critical safety net from sophisticated scams, including shell providers and improper billing in hospice and home-care programs.
當局正致力於瓦解透過醫療補助計畫取得處方藥並非法販售的陰謀。
A major area of concern is the intersection of these financial crimes with the national opioid epidemic.
為了解決這些問題，美國衛生與公共服務部(Department of Health and Human Services)正採取激進措施，例如扣留不合規州的聯邦資金。
Authorities are working to dismantle schemes where prescription drugs obtained through Medicaid are sold illicitly.
同時，國會正在考慮通過新法案，如《阻止尼他嗪法案》(STOP Nitazenes Act)，以應對合成鴉片類藥物的興起。
To combat these issues, the Department of Health and Human Services is taking aggressive steps, such as withholding federal funds from non-compliant states.
